David Rimm

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

David Rimm

Jan 21, 2025, 06:22 | Insight

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy

A recent paper by Miguel Lopez de Rodas, Associate Research Scientist in Pathology at Yale Cancer…

Apr 14, 2024, 13:29 | Blog

Elsa Anagnostou: So fortunate to have been mentored by David Rimm and Victor Velculescu

Elsa Anagnostou, Director of Molecular Oncology Lab, shared a post on X: "So fortunate to have been…

Nov 1, 2023, 18:47 | Career

Myrto K. Moutafi: Honored to receive the JITC Best Immunotherapy Biomarkers Paper award at SITC23

Myrto K. Moutafi, Oncology Resident at Attikon University Hospital, shared a post by Society for…

Oct 28, 2023, 01:25 | Blog

The Breast Cancer Research Foundation (BCRF) announced $60.2 million commitment to fund breast cancer research in 2023-2024 - Yale Cancer Center

Yale Cancer Center recently posted on LinkedIn. "The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board…

All: 4 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023